,X,FilingDate,TradeDate,Ticker,InsiderName,Title,TradeType,Price,Qty,Owned,delta_Own,Value,1d,1w,1m,6m,ticker
0,,2021-07-20 20:51:52,2021-07-19,FLXN,Willwerth Christina,Chief Strategy Officer,S - Sale,645.0,-3945,141241,-3%,-25445.0,,,,,FLXN
1,,2021-07-20 20:49:54,2021-07-19,FLXN,Wentworth Kerry,Chief Regulatory Officer,S - Sale,645.0,-3944,146362,-3%,-25439.0,,,,,FLXN
2,,2021-07-20 20:48:00,2021-07-19,FLXN,Muzikant Adam,Chief Business Officer,S - Sale,645.0,-1870,103666,-2%,-12062.0,,,,,FLXN
3,,2021-07-20 20:45:42,2021-07-19,FLXN,Levine Mark S.,GC,S - Sale,645.0,-3945,133486,-3%,-25445.0,,,,,FLXN
4,,2021-05-12 17:06:20,2021-05-10,FLXN,Arkowitz David,CFO,S - Sale,723.0,-2229,220719,-1%,-16116.0,,,,,FLXN
5,,2021-03-16 17:11:40,2021-03-15,FLXN,Layman Melissa,Chief Commercial Officer,S - Sale,1180.0,-4520,103956,-4%,-53336.0,,,,,FLXN
6,,2021-01-29 20:19:13,2021-01-28,FLXN,Layman Melissa,Chief Commercial Officer,S - Sale,1255.0,-2624,88376,-3%,-32931.0,,,,,FLXN
7,,2021-01-07 18:02:27,2021-01-05,FLXN,Muzikant Adam,Chief Business Officer,S - Sale,1113.0,-4005,73455,-5%,-44576.0,,,,,FLXN
8,,2021-01-07 17:58:33,2021-01-05,FLXN,Kelley Scott,Chief Medical Officer,S - Sale,1113.0,-6829,113549,-6%,-76007.0,,,,,FLXN
9,,2021-01-07 17:56:57,2021-01-05,FLXN,Wentworth Kerry,Chief Regulatory Officer,S - Sale,1113.0,-6829,119767,-5%,-76007.0,,,,,FLXN
10,,2021-01-07 17:55:19,2021-01-05,FLXN,Willwerth Christina,Chief Strategy Officer,S - Sale,1113.0,-6602,115186,-5%,-73480.0,,,,,FLXN
11,,2021-01-07 17:52:47,2021-01-05,FLXN,Levine Mark S.,GC,S - Sale,1113.0,-6829,107431,-6%,-76007.0,,,,,FLXN
12,,2021-01-07 17:50:04,2021-01-05,FLXN,Arkowitz David,CFO,S - Sale,1113.0,-6073,151048,-4%,-67592.0,,,,,FLXN
13,,2020-05-27 16:14:20,2020-05-26,FLXN,Stejbach Mark,Dir,P - Purchase,975.0,2051,3631,+130%,19997.0,,,,,FLXN
14,,2020-05-27 16:11:48,2020-05-26,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,975.0,10256,824845,+1%,99996.0,,,,,FLXN
15,,2020-05-11 16:11:08,2020-05-07,FLXN,Arkowitz David,CFO,S - Sale,1088.0,-2413,117068,-2%,-26253.0,,,,,FLXN
16,,2020-01-07 16:39:05,2020-01-03,FLXN,Willwerth Christina,Chief Strategy Officer,S - Sale,0.0,-3533,52473,-6%,-0.0,,,,,FLXN
17,,2020-01-07 16:37:58,2020-01-03,FLXN,Kelley Scott,Chief Medical Officer,S - Sale,0.0,-3724,49365,-7%,-0.0,,,,,FLXN
18,,2020-01-07 16:35:41,2020-01-03,FLXN,Levine Mark S.,GC,S - Sale,0.0,-3724,43487,-8%,-0.0,,,,,FLXN
19,,2020-01-07 16:33:06,2020-01-03,FLXN,Wentworth Kerry,Chief Regulatory Officer,S - Sale,0.0,-3724,56061,-6%,-0.0,,,,,FLXN
20,,2020-01-07 16:31:01,2020-01-03,FLXN,Arkowitz David,CFO,S - Sale,0.0,-3095,88481,-3%,-0.0,,,,,FLXN
21,,2020-01-07 16:28:24,2020-01-03,FLXN,Bodick Neil,Chief Scientific Officer,S - Sale,0.0,-3851,489836,-1%,-0.0,,,,,FLXN
22,,2019-08-09 16:05:41,2019-08-08,FLXN,Colella Samuel D,"Dir, 10%",P - Purchase,1074.0,2000,3996929,0%,21480.0,,,,,FLXN
23,,2019-08-08 16:38:12,2019-08-08,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,1085.0,2317,806026,0%,25136.0,,,,,FLXN
24,,2019-06-03 16:18:03,2019-05-31,FLXN,Arkowitz David,CFO,P - Purchase,1105.0,2500,89424,+3%,27627.0,,,,,FLXN
25,,2019-05-24 09:15:23,2019-05-23,FLXN,Merrifield C Ann,Dir,P - Purchase,1264.0,8000,10000,+400%,101120.0,,,,,FLXN
26,,2019-05-15 16:05:29,2019-05-13,FLXN,Arkowitz David,CFO,P - Purchase,1199.0,4000,86924,+5%,47960.0,,,,,FLXN
27,,2019-05-13 09:15:40,2019-05-10,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,1248.0,4012,802217,+1%,50067.0,,,,,FLXN
28,,2019-05-09 16:32:58,2019-05-08,FLXN,Arkowitz David,CFO,S - Sale,1006.0,-2248,82924,-3%,-22615.0,,,,,FLXN
29,,2019-03-13 16:11:48,2019-03-12,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,1236.0,4046,798205,+1%,50009.0,,,,,FLXN
30,,2019-01-04 17:12:25,2019-01-03,FLXN,Levine Mark S.,GC,S - Sale,1236.0,-734,9060,-7%,-9072.0,,,,,FLXN
31,,2019-01-04 17:10:53,2019-01-03,FLXN,Wentworth Kerry,Chief Regulatory Officer,S - Sale,1236.0,-622,17207,-3%,-7688.0,,,,,FLXN
32,,2019-01-04 17:09:22,2019-01-03,FLXN,Kelley Scott,Chief Medical Officer,S - Sale,1236.0,-622,15271,-4%,-7688.0,,,,,FLXN
33,,2019-01-04 17:06:16,2019-01-03,FLXN,Bodick Neil,Chief Scientific Officer,S - Sale,1236.0,-746,454465,0%,-9221.0,,,,,FLXN
34,,2019-01-04 17:03:59,2019-01-03,FLXN,Clayman Michael D.,"Pres, CEO",S - Sale,1236.0,-3278,794159,0%,-40516.0,,,,,FLXN
35,,2018-11-13 09:17:53,2018-11-09,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,1710.0,5000,796515,+1%,85477.0,,,,,FLXN
36,,2018-11-13 09:14:51,2018-11-09,FLXN,Arkowitz David,CFO,P - Purchase,1656.0,4000,48250,+9%,66222.0,,,,,FLXN
37,,2018-08-10 12:56:14,2018-08-09,FLXN,Arkowitz David,CFO,P - Purchase,2342.0,4000,44250,+10%,93680.0,,,,,FLXN
38,,2018-08-10 09:13:35,2018-08-09,FLXN,Clayman Michael D.,"Pres, CEO",P - Purchase,2233.0,10000,782948,+1%,223300.0,,,,,FLXN
39,M,2018-07-03 16:07:23,2018-07-02,FLXN,Bodick Neil,Chief Scientific Officer,S - Sale,2507.0,-50000,451990,-10%,-1253492.0,,,,,FLXN
